Patient Satisfaction With Virtual Postoperative Visit

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT04108442
Collaborator
(none)
122
1
2
7
17.4

Study Details

Study Description

Brief Summary

This is a prospective, randomized study designed to evaluate the effects of different initial postoperative follow-up modalities. Given the nature of the study, it is not possible for either the surgeons or the subjects to be blinded. To reduce bias that may occur due to each surgeon's personal preference for postoperative follow-up modality, the surgeons (rather than individual subjects) will be randomized to one of two postoperative follow-up modality groups (traditional or virtual).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Traditional
  • Behavioral: Virtual
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
122 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Patient Satisfaction With Virtual Postoperative Visit
Actual Study Start Date :
Aug 1, 2019
Actual Primary Completion Date :
Mar 1, 2020
Actual Study Completion Date :
Mar 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Traditional

Behavioral: Traditional
Surgeons (rather than individual subjects) will be randomized to traditional Postoperative follow-up modality groups. They will adhere to this form of postoperative follow-up for all of their surgical patients (subjects) for one month.

Experimental: Virtual

Behavioral: Virtual
Surgeons (rather than individual subjects) will be randomized to virtual postoperative follow-up modality group. They will adhere to that form of postoperative follow-up for all of their surgical patients (subjects) for one month.

Outcome Measures

Primary Outcome Measures

  1. Patient Satisfaction with their surgeon [6 Months]

    Patients will report their satisfaction with their surgical experience 6 weeks after surgery using a 10-point Likert scale, 0-"Completely Dissatisfied, 10-"Completely Satisfied"

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years old

  • < 60 years old

  • Undergoing knee arthroscopy procedure

Exclusion Criteria:
  • < 18 years old

  • 60 years old

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Kirk Campbell, MD, New York Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT04108442
Other Study ID Numbers:
  • 19-00549
First Posted:
Sep 30, 2019
Last Update Posted:
Oct 9, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2020